Implementing and Evaluating Genomic Screening Programs in Health Care Systems Proceedings of a Workshop (2018) / Chapter Skim
Currently Skimming:
Appendix B: Speaker Biographies
Appendix B: Speaker Biographies
Pages 113-122
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 113... ...
He has also directed the Human Genetics Center at the School of Public Health and the Brown Foundation Institute for Molecular Medicine for the Prevention of Human Diseases, which are a part of UTHealth. He holds the Kozmetsky Family Chair in Human Genetics at the School of Public Health as well.
|
From page 114... ...
-funded collaboration to evaluate evidence on breast cancer genomic applications. She was the co-principal investigator of the NCIfunded Grand Opportunity award CERGEN, which evaluated the cost, diffusion, and outcomes of KRAS testing to direct treatment decisions across 11 health care systems.
|
From page 115... ...
She co-directs Mount Sinai's Center for Health Equity and Community Engaged Research, the Sinai Clinical and Translational Science Award's Community Engaged Research Core; has been a principal investigator and investigator on numerous National Institutes of Health, the Centers for Disease Control and Research, and Patient-Centered Outcomes Research Institute (PCORI) grants related to chronic disease prevention and control; directs stakeholder engagement for the PCORI-funded New York City Clinical Data Research Network and chaired NHGRI's translational genomics consortium, IGNITE, and co-chairs NHGRI's CSER2 consortium.
|
From page 116... ...
Abel Kho, Ph.D., is an associate professor of medicine and preventive medicine in the Feinberg School of Medicine at Northwestern University and the director of the Center for Health Information Partnerships within the Institute for Public Health and Medicine. His research focuses on developing regional electronic health record (EHR)
|
From page 117... ...
, one of the Patient-Centered Outcomes Research Institute–funded clinical data research networks and also serves as a co-chair of the Data Standards, Security and Network Infrastructure Task Force of PCORnet. As a member of the eMERGE (Electronic Medical Records and Genomics)
|
From page 118... ...
He is a medical geneticist, pediatrician, and child neurologist, certified by the American Board of Medical Genetics (clinical genetics, clinical cytogenetics, clinical molecular genetics) , the American Board of Pediatrics, and the American Board of Psychiatry and Neurology (child neurology)
|
From page 119... ...
She also conducts research to assess the real-world utility of genomic testing and sequencing, including the impact of value-based contracts. Michael Murray, M.D., is board certified in internal medicine and medical genetics, and he joined Geisinger Health System as the director of clinical genomics in 2013 after serving on the faculty at Harvard Medical School and as the clinical chief of genetics at Brigham and Women's Hospital in Boston for 9 years.
|
From page 120... ...
She developed MeTree, a patient-facing family health history–based risk assessment and clinical decision support program designed to facilitate the uptake of risk-stratified evidence-based guidelines in primary care. MeTree was designed to overcome the major barriers to collecting and using high-quality family health histories to guide clinical care and has been shown to be highly effective when integrated into primary care practices.
|
From page 121... ...
His research focuses on cutting-edge health economics and outcomes research, particularly as they pertain to preference-based utility elicitation and health technology assessment. His current program includes the application of stated preference discrete choice experiments to health technologies and health promotion, the microeconometric analysis of discrete choice data, and probabilistic cost effectiveness and net-benefit analysis.
|
From page 122... ...
fellow on the North West England MRC CPT fellowship scheme, investigating the pharmacogenomics of statin-induced muscle toxicity. He has recently been awarded a Health Education England Genomics Education Programme Genomics Research and Innovation Fellowship, which will run over the next 4 years (2018–2021)
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.